Citation: B. Piatosa et al., PREVENTION OF THE OKT3 FIRST-DOSE SYNDROME BY REDUCED INITIAL DOSE FOLLOWED BY ADJUSTED BASES BASED ON CD3 T-LYMPHOCYTE COUNTS IN PEDIATRICRENAL GRAFT RECIPIENTS, Transplantation proceedings, 28(6), 1996, pp. 3466-3467
Citation: B. Piatosa et al., COMPARISON OF ADJUSTED-DOSE VS STANDARD-DOSE OKT3 THERAPY OF ACUTE REJECTION IN PEDIATRIC KIDNEY-TRANSPLANT RECIPIENTS, Transplantation proceedings, 25(4), 1993, pp. 2574-2574
Citation: S. Prokurat et al., GANCICLOVIR IN CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK PEDIATRIC RENAL-TRANSPLANT RECIPIENTS, Transplantation proceedings, 25(4), 1993, pp. 2577-2577